Bluebird Bio (BLUE): Revenue Growth QoQ

Corporate company logo of bluebird bio Inc. (BLUE)

The success of bluebird bio, Inc. (BLUE) is based on the commercialization of high-cost drugs and insurance reimbursements in the US and Europe. The company's quarterly revenue growth reflects the dynamics of these processes, where 108.50 captures the current value of the indicator. The issuer provides an alternative to lifelong treatment for rare blood pathologies, yet a rapid cash burn and FDA restrictions create serious liquidity risks.

bluebird bio Inc. (BLUE) - Quarterly Revenue Increase from 07/04/2022 to 06/07/2025

Financial and market metric breakdowns for bluebird bio (BLUE)

- stock price and consensus target price:
- cash and cash flow metrics:
Initial company analysis:bluebirdbio.com - BLUE
Mass-produced product of bluebirdbio.com

This indicator measures the relative rate of change in commercial revenues between quarters, allowing for an assessment of business scaling speeds and resilience to market shocks. By analyzing current quarterly revenue trends, an investor can identify the impact of geopolitical fragmentation and logistical disruptions on the implementation of gene therapies by bluebird bio, Inc. (BLUE), which critically determines the company's investment profile amid global isolation.

Competitors of bluebird bio, Inc.

TEM - Revenue Growth QoQ|Quarterly Sales Growth Rate qiagen.com QGEN|IONS: Quarterly Revenue Growth|Repligen Corp - Quarterly Revenue Increase|RNA (Avidity Corp) - Quarterly Revenue Growth|CRISPR Therapeutics Corp - Revenue Dynamics QoQ|Revenue Growth QoQ genedx.com (WGS)|Quarterly Revenue Growth ultragenyx.com (RARE)|Quarterly Revenue Growth BEAM (Beam Therapeutics Inc)|Sarepta Therapeutics Inc (SRPT) - Quarterly Revenue Growth Rate|twistbioscience.com - Quarterly Revenue Growth|10x Genomics, Inc. - Sales Change QoQ|NTLA (Intellia Corp) - Quarterly Sales Growth|Quarterly Sales Growth stoketherapeutics.com|Quarterly Sales Growth BLFS|Quarterly Sales Growth Wave Life Sciences Corp (WVE)|Quarterly Revenue Growth MAZE|Quarterly Sales Growth Rate Sionna Therapeutics Inc|Revenue Growth QoQ Prime Medicine Corp PRME|tayshagtx.com (TSHA) - Quarterly Revenue Growth Rate|QURE - Revenue Growth QoQ|MeiraGTx Holdings (MGTX) - Quarterly Sales Growth|Regenxbio (RGNX) - Revenue Growth QoQ|SLDB - Quarterly Sales Growth Rate|OCGN (Ocugen Inc) - Quarterly Revenue Growth|Revenue Growth QoQ PACB|Revenue Growth QoQ Benitec (BNTC)|Design Therapeutics Inc - Sales Growth QoQ|Revenue Growth QoQ Rocket Pharma RCKT|Quarterly Revenue Growth 4DMT FDMT|LXEO - Revenue Growth QoQ|Quarterly Revenue Growth Rate Korro Bio Inc.|EDIT: Quarterly Revenue Growth|SLN - Quarterly Sales Growth Rate|PRQR (ProQR Therapeutics) - Quarterly Revenue Growth|codexis.com (CDXS) - Quarterly Sales Growth Rate|Quarterly Revenue Growth SGMO|Quarterly Revenue Growth Nautilus Biotechnology, Inc. (NAUT)|Quarterly Revenue Growth MGX (Metagenomi Inc.)|Quarterly Revenue Increase DTIL|Generation Bio Co. - Quarterly Revenue Growth|BOLD: Revenue Growth QoQ|XCUR (Exicure, Inc.) - Quarterly Sales Growth|Sales Growth QoQ IMNN|Revenue Growth QoQ RXi Pharmaceuticals|mustangbio.com (MBIO) - Quarterly Sales Growth Rate|Revenue Growth QoQ TransCode (RNAZ)|Bionano Genomics Inc. - Sales Growth QoQ|Applied DNA Sciences - Quarterly Sales Growth|ImmunoPrecise Antibodies (IPA) - Quarterly Revenue Growth Rate|omegatherapeutics.com - Quarterly Revenue Growth|Revenue Change vs Previous Quarter Singular Genomics Systems Inc (OMIC)|RGLS: Quarterly Revenue Growth|Syros Pharmaceuticals, Inc (SYRS) - Quarterly Revenue Growth|TBIO (telesisbio.com) - Quarterly Revenue Growth|TCON: Quarterly Revenue Increase|Revenue Growth QoQ Unity Biotechnology, Inc (UBX)